X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (56) 56
humans (49) 49
male (38) 38
female (36) 36
adult (20) 20
middle aged (19) 19
pharmacology & pharmacy (18) 18
pharmacy (15) 15
research (12) 12
analysis (10) 10
pharmacists (10) 10
study and teaching (9) 9
young adult (9) 9
aged (8) 8
endocrinology & metabolism (8) 8
united states (8) 8
diabetes (7) 7
education (7) 7
education, scientific disciplines (7) 7
experiential education (7) 7
genetics & heredity (7) 7
adolescent (6) 6
arab americans (6) 6
arabs (6) 6
child (6) 6
child, preschool (6) 6
clinical education (6) 6
education, pharmacy - methods (6) 6
exenatide (6) 6
glucagon-like peptide-1 (6) 6
impaired glucose-tolerance (6) 6
life sciences (6) 6
patients (6) 6
risk factors (6) 6
students (6) 6
curricula (5) 5
diabetes mellitus, type 2 - drug therapy (5) 5
health aspects (5) 5
health education (5) 5
hypoglycemic agents - administration & dosage (5) 5
hypoglycemic agents - therapeutic use (5) 5
liraglutide (5) 5
risk (5) 5
students, pharmacy (5) 5
time factors (5) 5
type 2 diabetes (5) 5
article (4) 4
body mass index (4) 4
care and treatment (4) 4
clinical outcomes (4) 4
collaboration (4) 4
cross-sectional studies (4) 4
curriculum (4) 4
diabetes mellitus - ethnology (4) 4
follow-up studies (4) 4
genetic aspects (4) 4
hypoglycemic agents - adverse effects (4) 4
impact (4) 4
incretins (4) 4
infant (4) 4
methods (4) 4
mutation - genetics (4) 4
perception (4) 4
pharmaceutical sciences (4) 4
pharmacy practice (4) 4
phenotype (4) 4
physiological aspects (4) 4
prevention (4) 4
public, environmental & occupational health (4) 4
risk assessment (4) 4
surveys and questionnaires (4) 4
treatment outcome (4) 4
abridged index medicus (3) 3
activation (3) 3
adults (3) 3
animals (3) 3
blood glucose - metabolism (3) 3
children (3) 3
clinical competence (3) 3
clinical pharmacy (3) 3
complications (3) 3
core curriculum (3) 3
demographic aspects (3) 3
diabetes mellitus (3) 3
diabetes mellitus - prevention & control (3) 3
diabetes mellitus, type 2 - blood (3) 3
drug therapy (3) 3
drugstores (3) 3
dysfunction (3) 3
exendin-4 (3) 3
experiential learning (3) 3
feasibility studies (3) 3
genetics (3) 3
glucagon-like peptide 1 - therapeutic use (3) 3
glycemic control (3) 3
hypoglycemic agents - pharmacology (3) 3
implementation (3) 3
insulin (3) 3
introductory pharmacy practice experience (3) 3
layered learning practice model (3) 3
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, ISSN 1178-7007, 2012, Volume 5, pp. 165 - 174
The prevalence of obesity and diabetes continues to rise in the US. Glucagon-like peptide-1 receptor agonist (GLP-1RA) is an effective treatment option for... 
Type 2 diabetes | GLP-1 | Exenatide | Liraglutide | Lixisenatide | Dosage and administration | Drug therapy, Combination | Research | Drug therapy | Insulin | Diabetes | Peptides | Evidence-based medicine | liraglutide | type 2 diabetes | lixisenatide | exenatide
Journal Article
AMERICAN JOURNAL OF PHARMACEUTICAL EDUCATION, ISSN 0002-9459, 2019, Volume 83, Issue 2, pp. 212 - 223
Journal Article
Annals of Pharmacotherapy, ISSN 1060-0280, 7/2011, Volume 45, Issue 7-8, pp. 850 - 860
Background: Long-acting glucagon-like peptide-1 receptor agonists (LA-GLP-1RAs) may deliver additional therapeutic benefits over other available incretin-based... 
liraglutide | METFORMIN | incretins | GLYCEMIC CONTROL | DRUG-THERAPY | glucagon-like peptide-1 | WEIGHT-LOSS | OPEN-LABEL | TREATED PATIENTS | sitagliptin | type 2 diabetes | EXENDIN-4 | PARALLEL-GROUP | DOUBLE-BLIND | PHARMACOLOGY & PHARMACY | dipeptidyl peptidase IV inhibitor | exenatide | Glycated Hemoglobin A - analysis | Triazoles - adverse effects | Glucagon-Like Peptide 1 - administration & dosage | Dipeptidyl-Peptidase IV Inhibitors - adverse effects | Dipeptidyl-Peptidase IV Inhibitors - therapeutic use | Humans | Middle Aged | Male | Pyrazines - therapeutic use | Peptides - administration & dosage | Delayed-Action Preparations - administration & dosage | Hypoglycemic Agents - administration & dosage | Glucagon-Like Peptide 1 - agonists | Venoms - administration & dosage | Female | Sitagliptin Phosphate | Triazoles - therapeutic use | Hypoglycemic Agents - therapeutic use | Receptors, Glucagon - agonists | Hyperglycemia - prevention & control | Glucagon-Like Peptide 1 - analogs & derivatives | Venoms - adverse effects | Dipeptidyl-Peptidase IV Inhibitors - administration & dosage | Randomized Controlled Trials as Topic | Diabetes Mellitus, Type 2 - blood | Delayed-Action Preparations - adverse effects | Glucagon-Like Peptide-1 Receptor | Incretins - adverse effects | Incretins - agonists | Pyrazines - adverse effects | Venoms - therapeutic use | Delayed-Action Preparations - therapeutic use | Incretins - therapeutic use | Diabetes Mellitus, Type 2 - drug therapy | Glucagon-Like Peptide 1 - adverse effects | Hypoglycemic Agents - adverse effects | Incretins - administration & dosage | Liraglutide | Peptides - adverse effects | Peptides - therapeutic use | Glucagon-Like Peptide 1 - therapeutic use
Journal Article
AMERICAN JOURNAL OF PHARMACEUTICAL EDUCATION, ISSN 0002-9459, 2018, Volume 82, Issue 6, pp. 637 - 640
Journal Article
The Journal of Clinical Endocrinology & Metabolism, ISSN 0021-972X, 10/2011, Volume 96, Issue 10, pp. E1680 - E1683
Journal Article
by Auffret, Vincent and Lefevre, Thierry and Van Belle, Eric and Eltchaninoff, Hélène and Iung, Bernard and Koning, René and Motreff, Pascal and Leprince, Pascal and Verhoye, Jean Philippe and Manigold, Thibaut and Souteyrand, Geraud and Boulmier, Dominique and Joly, Patrick and Pinaud, Frédéric and Himbert, Dominique and Collet, Jean Philippe and Rioufol, Gilles and Ghostine, Said and Bar, Olivier and Dibie, Alain and Champagnac, Didier and Leroux, Lionel and Collet, Frédéric and Teiger, Emmanuel and Darremont, Olivier and Folliguet, Thierry and Leclercq, Florence and Lhermusier, Thibault and Olhmann, Patrick and Huret, Bruno and Lorgis, Luc and Drogoul, Laurent and Bertrand, Bernard and Spaulding, Christian and Quilliet, Laurent and Cuisset, Thomas and Delomez, Maxence and Beygui, Farzin and Claudel, Jean-Philippe and Hepp, Alain and Jegou, Arnaud and Gommeaux, Antoine and Mirode, Anfani and Christiaens, Luc and Christophe, Charles and Cassat, Claude and Metz, Damien and Mangin, Lionel and Isaaz, Karl and Jacquemin, Laurent and Guyon, Philippe and Pouillot, Christophe and Makowski, Serge and Bataille, Vincent and Rodés-Cabau, Josep and Gilard, Martine and Le Breton, Hervé and Le Breton, Hervé and Eltchaninoff, Hélène and Gilard, Martine and Iung, Bernard and Le Breton, Hervé and Lefevre, Thierry and Van Belle, Eric and Laskar, Marc and Leprince, Pascal and Iung, Bernard and Bataille, Vincent and Chevalier, Bernard and Garot, Philippe and Hovasse, Thomas and Lefevre, Thierry and Donzeau Gouge, Patrick and Farge, Arnaud and Romano, Mauro and Cormier, Bertrand and Bouvier, Erik and Bauchart, Jean-Jacques and Bodart, Jean-Christophe and Delhaye, Cédric and Houpe, David and Lallemant, Robert and Leroy, Fabrice and Sudre, Arnaud and Van Belle, Eric and Juthier, Francis and Koussa, Mohamed and Modine, Thomas and Rousse, Natacha and Auffray, Jean-Luc and Richardson, Marjorie and Berland, Jacques and Eltchaninoff, Hélène and Godin, Mathieu and Koning, René and Bessou, Jean-Paul and Letocart, Vincent and Manigold, Thibaut and Roussel, Jean-Christian and Jaafar, Philippe and ... and FRANCE TAVI Investigators
Journal of the American College of Cardiology, ISSN 0735-1097, 07/2017, Volume 70, Issue 1, pp. 42 - 55
Journal Article
Human Genetics, ISSN 0340-6717, 2015, Volume 134, Issue 1, pp. 123 - 126
Journal Article
American Journal of Health-System Pharmacy, ISSN 1079-2082, 12/2016, Volume 73, Issue 24, pp. 2077 - 2082
Journal Article
Journal of Oncology Pharmacy Practice, ISSN 1078-1552, 6/2019, Volume 25, Issue 4, pp. 896 - 902
Background Healthcare systems and policy makers worldwide are demonstrating interest in shared decision making, which requires patient activation. Patient... 
MEDICATION THERAPY MANAGEMENT | Chemotherapy | ONCOLOGY | patient activation | patient education | pharmacist | PHARMACOLOGY & PHARMACY | LITERACY | patient engagement | CARE | Health care | Decision making | Pharmacy | Consultation | Activation | Solid tumors | Patients | Cancer
Journal Article
American Journal of Health-System Pharmacy, ISSN 1079-2082, 12/2019, Volume 76, Issue 24, pp. 2070 - 2076
Purpose. Pharmacy departments and schools of pharmacy have long held professional affiliations. However, the success of each entity is often not interdependent... 
practice advancement | FACULTY | experiential education | pharmacy | PHARMACOLOGY & PHARMACY | pharmacy practice | clinical education | educational partnerships
Journal Article
Annals of Pharmacotherapy, ISSN 1060-0280, 05/2012, Volume 46, Issue 5, pp. 710 - 717
Journal Article